Loading clinical trials...
Loading clinical trials...
This non-randomized, open-label, multicenter study will evaluate the safety and efficacy of alectinib in participants with ALK-rearranged non-small cell lung cancer who failed crizotinib treatment. In...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hoffmann-La Roche
NCT07489716 · Non-Small Cell Lung Cancer
NCT07444437 · Non-Small Cell Lung Cancer
NCT07300150 · Colorectal Cancer, Pancreatic Cancer, and more
NCT07154290 · Advanced/Metastatic Non-Small Cell Lung Cancer
NCT06043817 · Non-Small Cell Lung Cancer, NSCLC, and more
University of Alabama at Birmingham
Birmingham, Alabama
University of California Irvine
Irvine, California
UCSD Moores Cancer Center
La Jolla, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions